276 related articles for article (PubMed ID: 26502167)
21. Prognostic factors for conjunctival melanoma: a study in ethnic Chinese patients.
Sheng X; Li S; Chi Z; Si L; Cui C; Mao L; Lian B; Tang B; Wang X; Yan X; Kong Y; Dai J; Guo J
Br J Ophthalmol; 2015 Jul; 99(7):990-6. PubMed ID: 25595173
[TBL] [Abstract][Full Text] [Related]
22. Two cases of BRAF-mutated, bulbar conjunctival melanoma, and review of the published literature.
Kiyohara T; Tanimura H; Miyamoto M; Shijimaya T; Nagano N; Nakamaru S; Makimura K; Iwai H
Clin Exp Dermatol; 2020 Mar; 45(2):207-211. PubMed ID: 31361915
[TBL] [Abstract][Full Text] [Related]
23. Conjunctival melanoma in the Netherlands: a nationwide study.
Missotten GS; Keijser S; De Keizer RJ; De Wolff-Rouendaal D
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):75-82. PubMed ID: 15623757
[TBL] [Abstract][Full Text] [Related]
24. [Two cases of conjunctival malignant melanoma treated with topical interferon alpha-2b drop as an adjuvant therapy].
Kase S; Ishijima K; Noda M; Ishida S
Nippon Ganka Gakkai Zasshi; 2011 Nov; 115(11):1043-7. PubMed ID: 22171510
[TBL] [Abstract][Full Text] [Related]
25. Surgical management of circumscribed conjunctival melanomas.
Shields JA; Shields CL; De Potter P
Ophthalmic Plast Reconstr Surg; 1998 May; 14(3):208-15. PubMed ID: 9612814
[TBL] [Abstract][Full Text] [Related]
26. A Retrospective Review of Conjunctival Melanoma Presentation, Treatment, and Outcome and an Investigation of Features Associated With BRAF Mutations.
Larsen AC; Dahmcke CM; Dahl C; Siersma VD; Toft PB; Coupland SE; Prause JU; Guldberg P; Heegaard S
JAMA Ophthalmol; 2015 Nov; 133(11):1295-303. PubMed ID: 26425792
[TBL] [Abstract][Full Text] [Related]
27. Clinical Management of Uveal and Conjunctival Melanoma.
Blum ES; Yang J; Komatsubara KM; Carvajal RD
Oncology (Williston Park); 2016 Jan; 30(1):29-32, 34-43, 48. PubMed ID: 26791842
[TBL] [Abstract][Full Text] [Related]
28. Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex.
Finger PT; Sedeek RW; Chin KJ
Am J Ophthalmol; 2008 Jan; 145(1):124-129. PubMed ID: 17981257
[TBL] [Abstract][Full Text] [Related]
29. Conjunctival malignant melanoma.
Bajaj MS; Pushker N; Kashyap S; Balasubramanya R; Chandra M; Ghose S
Orbit; 2003 Mar; 22(1):47-53. PubMed ID: 12759867
[TBL] [Abstract][Full Text] [Related]
30. [Adjuvant topical interferon-alpha-2b treatment in epithelial tumors of the ocular surface].
Fuchsluger TA; Hintschich C; Steuhl KP; Meller D
Ophthalmologe; 2006 Feb; 103(2):124-8. PubMed ID: 16047150
[TBL] [Abstract][Full Text] [Related]
31. Use of interferon alpha 2b to manage conjunctival primary acquired melanosis and conjunctival melanoma.
Cid-Bertomeu P; Huerva V
Surv Ophthalmol; 2022; 67(5):1391-1404. PubMed ID: 35278438
[TBL] [Abstract][Full Text] [Related]
32. Clinical treatment options for early-stage and advanced conjunctival melanoma.
Zeng Y; Hu C; Shu L; Pan Y; Zhao L; Pu X; Wu F
Surv Ophthalmol; 2021; 66(3):461-470. PubMed ID: 32980421
[TBL] [Abstract][Full Text] [Related]
33. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience.
Kurli M; Finger PT
Graefes Arch Clin Exp Ophthalmol; 2005 Nov; 243(11):1108-14. PubMed ID: 15940485
[TBL] [Abstract][Full Text] [Related]
34. Late Solitary Extraocular Recurrence From Previously Resected Iris Melanoma.
Fabian ID; Thaung C; AlHarby L; Sisley K; Mudhar HS; Doherty RE; Stacey AW; Arora AK; Cohen VML; Sagoo MS
Am J Ophthalmol; 2017 Sep; 181():97-105. PubMed ID: 28673748
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic outcome of patients suffering from malignant melanomas of the conjunctiva.
Lommatzsch PK; Lommatzsch RE; Kirsch I; Fuhrmann P
Br J Ophthalmol; 1990 Oct; 74(10):615-9. PubMed ID: 2285686
[TBL] [Abstract][Full Text] [Related]
36. Hughes technique, amniotic membrane allograft, and topical chemotherapy in conjunctival melanoma with eyelid involvement.
Becerra EM; Blanco G; Saornil MA; del C Méndez M; Bianciotto CG
Ophthalmic Plast Reconstr Surg; 2005 May; 21(3):238-40. PubMed ID: 15942504
[TBL] [Abstract][Full Text] [Related]
37. [Clinical findings and prognosis of 11 cases of conjunctival malignant melanoma].
Kimura K; Usui Y; Goto H
Nippon Ganka Gakkai Zasshi; 2012 May; 116(5):503-9. PubMed ID: 22690541
[TBL] [Abstract][Full Text] [Related]
38. Conjunctival papilloma: features and outcomes based on age at initial examination.
Kaliki S; Arepalli S; Shields CL; Klein K; Sun H; Hysenj E; Lally SE; Shields JA
JAMA Ophthalmol; 2013 May; 131(5):585-93. PubMed ID: 23538642
[TBL] [Abstract][Full Text] [Related]
39. [Diagnosis and Therapy of Benign and Malignant Tumors of the Conjunctiva].
Westekemper H; Manthey A; Bechrakis N
Klin Monbl Augenheilkd; 2020 Sep; 237(9):1143-1159. PubMed ID: 32777832
[TBL] [Abstract][Full Text] [Related]
40. Factors affecting recurrence and metastasis in conjunctival melanoma.
Çalış Karanfil F; Gündüz AK; Gündüz ÖÖ; Özalp Ateş FS
Int Ophthalmol; 2023 Nov; 43(11):4203-4215. PubMed ID: 37639080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
